Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow

Vascular Pharmacology

Volumn 51, Issue 5-6, 2009, Pages 359-364

  Sharma, Shruti ^a   Kumar, Sanjiv ^a   Sud, Neetu ^a   Wiseman, Dean A ^a   Tian, Jing ^a   Rehmani, Imran ^a   Datar, Sanjeev ^b   Oishi, Peter ^b   Fratz, Sohrab ^d   Venema, Richard C ^a   Fineman, Jeffrey R ^b,c   Black, Stephen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arginase; Argininosuccinate lyase; Argininosuccinate synthetase; Cationic amino acid transporter 1; Pulmonary hypertension

Indexed keywords

ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; LAMB; LUNG BLOOD FLOW; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ARGINASE; ARGININE; BLOOD PRESSURE; FEMALE; HYPERTENSION, PULMONARY; LUNG; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PREGNANCY; PULMONARY CIRCULATION; SHEEP;

EID: 70449525329     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.09.005     Document Type: Article

References (24)

1. Barr F., Tirona R., Taylor M., Rice G., Arnold J., Cunningham G., Smith H., Campbell A., Canter J.A., Christian K., Drinkwater D., Scholl F., Kavanaugh-McHugh A., and Summar M. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 134 (2007) 319-326
2. Black S.M., Heidersbach R.S., McMullan D.M., Bekker J.M., Johengen M.J., and Fineman J.R. Inhaled nitric oxide inhibits NOS activity in lambs: a potential mechanism for rebound pulmonary hypertension. Am. J. Physiol. 277 (1999) H1849-H1856
3. Dhanakoti S.N., Brosnan M.E., Herzberg G.R., and Brosnan J.T. Cellular and subcellular localization of enzymes of arginine metabolism in rat kidney. Biochem. J. 282 Pt 2 (1992) 369-375
4. Erbas H., Aydogdu N., and Kaymak K. Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury. Pharmacol. Res. 50 (2004) 523-527
5. Gorenflo M., Zheng C., Pöge A., Bettendorf M., Werle E., Fiehn W., and Ulmer H. Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt. Clin. Lab. 47 (2001) 441-447
6. Gutierrez J.A., Parry A.J., McMullan D.M., Chapin C.J., and Fineman J.R. Decreased surfactant proteins in lambs with pulmonary hypertension secondary to increased blood flow. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L1264-1270
7. Hsieh C.L., Hsiung K.P., and Su J.C. Determination of lysine with ninhydrin-ferric reagent. Anal. Biochem. 224 (1995) 187-189
8. Kumar S., Sun X., Wedgwood S., and Black S.M. Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. Am. J. Physiol. Lung Cell Mol. Physiol. 295 (2008) L370-377
9. Liu H., Drew P., Gaugler A.C., Cheng Y., and Visner G.A. Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway. Am. J. Transplant 5 (2005) 1256-1263
10. McDonald K.K., Zharikov S., Block E.R., and Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J. Biol. Chem. 272 (1997) 31213-31216
11. Morris C.R., Morris Jr. S.M., Hagar W., Van Warmerdam J., Claster S., Kepka-Lenhart D., Machado L., Kuypers F.A., and Vichinsky E.P. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?. Am. J. Respir. Crit. Care Med. 168 (2003) 63-69
12. Morris C.R., Kato G.J., Poljakovic M., Wang X., Blackwelder W.C., Sachdev V., Hazen S.L., Vichinsky E.P., Morris Jr. S.M., and Gladwin M.T. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Jama. 294 (2005) 81-90
13. Nicholls S.J., Wang Z., Koeth R., Levison B., DelFraino B., Dzavik V., Griffith O.W., Hathaway D., Panza J.A., Nissen S.E., Hochman J.S., and Hazen S.L. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation 116 (2007) 2315-2324
14. Pearson D.L., Dawling S., Walsh W.F., Haines J.L., Christman B.W., Bazyk A., Scott N., and Summar M.L. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N. Engl. J. Med. 344 (2001) 1832-1838
15. Reddy V.M., Meyrick B., Wong J., Khoor A., Liddicoat J.R., Hanley F.L., and Fineman J.R. In utero placement of aortopulmonary shunts: a model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92 (1995) 1-8
16. Reddy V.M., Wong J., Liddicoat J.R., Johengen M., Chang R., and Fineman J.R. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am. J. Physiol. 271 (1996) H562-570
17. Ryoo S., Lemmon C.A., Soucy K.G., Gupta G., White A.R., Nyhan D., Shoukas A., Romer L.H., and Berkowitz D.E. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ. Res. 99 (2006) 951-960
18. Sharma S., Sud N., Wiseman D.A., Carter A.L., Kumar S., Hou Y., Rau T., Wilham J., Harmon C., Oishi P., Fineman J.R., and Black S.M. Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 294 (2008) L46-56
19. Smith H., Canter J., Christian K., Drinkwater D., Scholl F., Christman B., Rice G., Barr F., and Summar M. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J. Thorac. Cardiovasc. Surg. 132 (2006) 58-65
20. Steinhorn R., Russell J., Lakshminrusimha S., Gugino S., Black S., and Fineman J. Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H311-H317
21. Sud N., Sharma S., Wiseman D.A., Harmon C., Kumar S., Venema R.C., Fineman J.R., and Black S.M. Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L1444-1453
22. Sud N., Wells S.M., Sharma S., Wiseman D.A., Wilham J., and Black S.M. Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am. J. Physiol. Cell Physiol. 294 (2008) C1407-1418
23. Wu G., Knabe D.A., and Flynn N.E. Synthesis of citrulline from glutamine in pig enterocytes. Biochem. J. 299 Pt 1 (1994) 115-121
24. Xu W., Kaneko F.T., Zheng S., Comhair S.A., Janocha A.J., Goggans T., Thunnissen F.B., Farver C., Hazen S.L., Jennings C., Dweik R.A., Arroliga A.C., and Erzurum S.C. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. Faseb J. 18 (2004) 1746-1748